blinatumomab: Clinical Trials

3 trials of blinatumomab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting, 1 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Not yet recruiting 1, Recruiting 1, Terminated 1

Follow blinatumomab: new trials by email Literature Review of blinatumomab trials Research Report on blinatumomab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis
Blinatumomab - Autoimmune Encephalitis (AE), Autoimmune Cerebellitis
Phase 4Not yet recruitingBeijing Tiantan Hospital122026-06-242026-07-06
Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
Blinatumomab - Acute B-cell Lymphoblastic Leukemia
Phase 4RecruitingSuping ZHANG602023-09-012024-04-01
Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)
Blinatumomab, Current Wearable Heatlth Monitoring System (CWHMS) - B-precursor Acute Lymphoblastic Leukemia
Phase 4TerminatedAmgen102021-08-262025-05-18

Conditions studied

Autoimmune Diseases of the Nervous System (1)  ·  Leukemia (1)  ·  Neoplasm, Residual (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)

Sponsors

Amgen (1)  ·  Beijing Tiantan Hospital (1)  ·  Suping ZHANG (1)

Countries

China (2)  ·  United States (1)

Top investigators

Wangshu Xu (1)

Results publications

PMID 41671463